Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_734_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
51 Мб
Скачать
324
14. Brozzetti S, Bini S, De Lio N, Lombardo C, Boggi U.Surgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma- quality of life and survival analy­sis. BMC Surg. 2020;20(1):101.
15. Yoon J, Petrosyan A, Wang T, Ameer A.Colonic adenocarcinoma with synchronous metastasis to the pancreas: a case report and literature review. JGH Open. 2022;6(4):274–6.
16. Olesinski T, Milewska J, Symonides M, Palucki J, Mróz A, Rutkowski A.Pancreatic metastases of rectal cancer-case report and literature review. J Gastrointest Cancer. 2019;50(2):338–41.
17. Tani R, Hori T, Yamada M, etal. Metachronous pancreatic metastasis from rectal cancer that masqueraded as a primary pancreatic cancer: a rare and difcult-to-diagnose metastatic tumor in the pancreas. Am J Case Rep. 2019;20:1781–7.
18. Su L, Wernberg J.Synchronous distal pancreatic metastatic lesion arising from colonic adeno­carcinoma: case report and literature review. Clin Med Res. 2014;12(3–4):166–70.
19. Lee CW, Wu RC, Hsu JT, etal. Isolated pancreatic metastasis from rectal cancer: a case report and review of literature. World J Surg Oncol. 2010;8:26.
20. McDaniel KP, Charnsangavej C, DuBrow RA, Varma DG, Graneld CA, Curley SA.Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol. 1993;161(1):61–4.
21. Sano I, Katanuma A, Yane K, etal. Pancreatic metastasis from rectal cancer that was diag­nosed by endoscopic ultrasonography-guided ne needle aspiration (EUS-FNA). Intern Med. 2017;56(3):301–5.
22. Pang JC, Roh MH.Metastases to the pancreas encountered on endoscopic ultrasound-guided, ne-needle aspiration. Arch Pathol Lab Med. 2015;139(10):1248–52.
23. Nakamura Y, Yamada R, Kaneko M, etal. Isolated pancreatic metastasis from malignant mela­noma: a case report and literature review. Clin J Gastroenterol. 2019;12(6):626–36.
24. McLoughlin JM, Zager JS, Sondak VK, Berk LB.Treatment options for limited or symptom­atic metastatic melanoma. Cancer Control. 2008;15(3):239–47.
25. Nikfarjam M, Evans P, Christophi C. Pancreatic resection for metastatic melanoma. HPB (Oxford). 2003;5(3):174–9.
26. Sperti C, Polizzi ML, Beltrame V, Moro M, Pedrazzoli S.Pancreatic resection for metastatic melanoma. Case report and review of the literature. J Gastrointest Cancer. 2011;42(4):302–6.
27. Yagi T, Hashimoto D, Taki K, etal. Surgery for metastatic tumors of the pancreas. Surg Case Rep. 2017;3(1):31.
28. Rinne D, Baum RP, Hor G, Kaufmann R.Primary staging and follow-up of high risk melanoma patients with whole-body 18F-uorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer. 1998;82(9):1664–71.
29. Tsitouridis I, Diamantopoulou A, Michaelides M, Arvanity M, Papaioannou S. Pancreatic metastases: CT and MRI ndings. Diagn Interv Radiol. 2010;16(1):45–51.
30. Franz D, Esposito I, Kapp AC, Gaa J, Rummeny EJ.Magnetic resonance imaging of less com­mon pancreatic malignancies and pancreatic tumors with malignant potential. Eur J Radiol Open. 2014;1:49–59.
31. Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neo­plasms. Eur J Radiol. 2001;38(2):113–9.
32. Fusaroli P, D'Ercole MC, De Giorgio R, Serrani M, Caletti G.Contrast harmonic endoscopic ultrasonography in the characterization of pancreatic metastases (with video). Pancreas. 2014;43(4):584–7.
33. Vargas-Jiménez J, Vargas-Madrigal J, Arias-Mora R, Ulate-Ovares D, Solis-Ugalde B. Pancreatic metastasis from malignant melanoma: not all that glitters is gold. Case Rep Gastroenterol. 2021;15(1):131–6.
34. Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T.Endoscopic ultrasound­guided ne-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol. 2005;40(11):1013–23.
35. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35(5):433–44.
R. Mudgway et al.
18 Secondary Malignant Neoplasms
36. Birnbaum DJ, Moutardier V, Turrini O, Gonçalves A, Delpero JR.Isolated pancreatic metas­tasis from malignant melanoma: is pancreatectomy worthwile? J Surg Tech Case Rep. 2013;5(2):82–4.
37. Goyal J, Lipson EJ, Rezaee N, etal. Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer. 2012;43(3):431–6.
38. Wood TF, DiFronzo LA, Rose DM, etal. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8(8):658–62.
39. Bassi C, Butturini G, Falconi M, Sargenti M, Mantovani W, Pederzoli P. High recurrence rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg. 2003;90(5):555–9.
40. Reddy S, Wolfgang CL.The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009;10(3):287–93.
41. Larsen AK, Krag C, Geertsen P, Jakobsen LP.Isolated malignant melanoma metastasis to the pancreas. Plast Reconstr Surg Glob Open. 2013;1(8):e74.
42. Schuchter LM, Green R, Fraker D.Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Curr Opin Oncol. 2000;12(2):181–5.
43. Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R.Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol. 2010;21(5):1106–11.
44. Lee M, Song JS, Hong SM, etal. Sarcoma metastasis to the pancreas: experience at a single institution. J Pathol Transl Med. 2020;54(3):220–7.
45. Cirotski D, Panicker J. Parosteal osteosarcoma with pancreatic metastasis and multiple relapses: a case report and review of the literature. Case Rep Oncol. 2021;2021(2):983–8.
46. Chen JJ, Chou CW. A rare case report of mesenchymal chondrosarcoma with pancreatic metastasis. Medicina (Kaunas). 2022;58(5):639.
47. Ishizaki A, Okuwaki K, Kida M, etal. The rst case of metastatic pancreatic leiomyosarcoma derived from the urinary bladder diagnosed using an endoscopic ultrasound-guided ne-needle biopsy. Intern Med. 2021;60(9):1377–81.
48. Chilukuri DS, Premkumar P, Venkitaraman B, Soundararajan JCB. Pancreatic metastasis of dermatobrosarcoma protuberans: a rare case. BMJ Case Rep. 2020;13(1):e232614.
49. Narayan RR, Charville GW, Delitto D, Ganjoo KN.First recurrence of synovial sarcoma pre­senting with solitary pancreatic mass. Cureus. 2022;14(6):e26356.
50. Polimera H, Moku P, Abusharar SP, Vasekar M, Chintanaboina J.Metastasis of ewing sarcoma to the pancreas: case report and literature review. Case Rep Oncol Med. 2020;2020:7075048.
51. Leong SP, Cady B, Jablons DM, etal. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006;25(2):221–32.
52. Pennacchioli E, Tosti G, Barberis M, et al. Sarcoma spreads primarily through the vascu­lar system: are there biomarkers associated with vascular spread? Clin Exp Metastasis. 2012;29(7):757–73.
53. Huddy JR, Sodergren MH, Deguara J, Thway K, Jones RL, Mudan SS. Pancreaticoduodenectomy for the management of pancreatic or duodenal metastases from primary sarcoma. Anticancer Res. 2018;38(7):4041–6.
54. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC.Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer. 1986;57(12):2444–53.
55. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, Ferrari S.Mesenchymal chondrosar­coma. An analysis of patients treated at a single institution. Tumori. 2007;93(5):423–7.
56. Yokoyama Y, Murakami Y, Sasaki M, etal. Pancreatic metastasis of dermatobrosarcoma pro­tuberans. J Gastroenterol. 2004;39(8):798–800.
57. Mahajan BB, Sumir K, Singla M.Metastatic dermatobrosarcoma protuberans: a rare case report from North India. J Cancer Res Ther. 2015;11(3):670.
58. Spurrell EL, Fisher C, Thomas JM, Judson IR. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol. 2005;16(3):437–44.
325
326
59. Bakri A, Shinagare AB, Krajewski KM, etal. Synovial sarcoma: imaging features of com­mon and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199(2):W208–15.
60. Fletcher CDM, Unni KK, Mertens F, World Health Organization, International Agency for Research on Cancer. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. 427p.
61. Syed M, Mushtaq S, Loya A, Hassan U.NKX3.1 a useful marker for mesenchymal chondro­sarcoma: An immunohistochemical study. Ann Diagn Pathol. 2021;50:151660.
62. Noujaim J, Thway K, Sheri A, Keller C, Jones RL.Histology-driven therapy: the importance of diagnostic accuracy in guiding systemic therapy of soft tissue tumors. Int J Surg Pathol. 2016;24(1):5–15.
63. Strobel O, Hackert T, Hartwig W, etal. Survival data justies resection for pancreatic metasta­ses. Ann Surg Oncol. 2009;16(12):3340–9.
64. Ladenstein R, Potschger U, Le Deley MC, etal. Primary disseminated multifocal Ewing sar­coma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010;28(20):3284–91.
65. Sperti C, Moletta L, Patane G.Metastatic tumors to the pancreas: the role of surgery. World J Gastrointest Oncol. 2014;6(10):381–92.
R. Mudgway et al.
Part V
Surgical Technique—
Pancreatoduodenectomy
Chapter 19
Open Whipple
RachelC.Kim, JacksonA.Baril, andTrangK.Nguyen
Introduction andHistory
In 1898, Alessandro Codivilla attempted the rst documented radical pancreatoduo­denectomy for an “epithelioma,” or carcinoma of the pancreas, when he was forced to perform an en bloc resection rather than the preferred enucleation at that time since the tumor was adherent to duodenum. Codivilla’s patient died from cachexia 21days after the procedure after experiencing wound drainage, “foul diarrhea,” and eventually drainage of “milky clots,” likely from a pancreatic stula [1]. Soon after, William Halsted was the rst to successfully resect a periampullary cancer, with a transduodenal approach and performing a wedge resection with adjacent segments of the pancreatic and common bile ducts, reimplanting both into the duodenum dur­ing the primary closure of the duodenal defect. The patient survived the operation, although still died within a year due to local recurrence of the cancer [2].
In the following decades, there would be several advances in the eld of pancre­atic surgery. Most notably, in 1935, Allen Oldfather Whipple, Surgeon-in-Chief at Columbia-Presbyterian Medical Center, published his rst report on the radical resection of the head of the pancreas and duodenum in three patients. His initial technique was composed of a two-staged procedure, the rst consisting of a chole­cystogastrostomy and posterior loop gastrojejunostomy, the second composed of the partial duodenal and head of pancreas resection. The pancreatic stump was occluded [3]. Whipple would continue to make advancements in his technique, including condensing the surgery into a one-stage procedure, and in 1946, he
R. C. Kim · J. A. Baril Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA e-mail: rckim@iu.edu; jbaril@iu.edu
T. K. Nguyen ( Division of Surgical Oncology, Washington University in St. Louis, St. Louis, MO, USA e-mail: ntrang@wustl.edu
Switzerland AG 2025 E. P. Ceppa et al. (eds.), The SAGES Manual of Evolving Techniques in Pancreatic Surgery, https://doi.org/10.1007/978-3-031-78409-5_19
*)
329© The Author(s), under exclusive license to Springer Nature
330
published his 10-year experience of 37 patients who underwent pancreaticoduode­nectomy [4].
The Whipple operation was adapted and advanced outside of its eponym’s expe­rience. For instance, Whipple was initially averse to reconstructing the pancreatic duct, believing the anastomosis would place the other anastomoses at risk due to the activation of pancreatic enzymes in the duodenum. However, this approach led to frequent pancreatic stulas, and in 1941, Verne Hunt successfully incorporated a pancreaticojejunostomy procedure to avoid pancreatic stump leakage [5]. This sur­gery of the pancreas also show high rates of marginal ulceration until the gastric anastomosis was moved from the most proximal to the most distal of the anastomo­ses, and adequate gastrectomy was routinely practiced [6]. In 1978, Traverso and Longmire reintroduced the idea of pylorus preservation, rst described by Kenneth Watson in 1944, further reducing the frequency of marginal ulcers [7, 8]. The 1980s and beyond saw the dramatic reduction in mortality rates following the Whipple procedure from 20% to 40% to <5%, attributed to the centralization of this complex operation to high-volume centers and pioneered under the leadership of John Cameron at Johns Hopkins Hospital [911].
R. C. Kim et al.

Preoperative Considerations

Preoperative Work-Up andPlanning
All patients should undergo cross-sectional imaging prior to scheduled pancreato­duodenectomy, regardless of pathology. A high-quality CT “pancreas protocol” or magnetic resonance imaging (MRI) is recommended to dene the anatomy. MRI may be particularly useful in evaluating small (<2cm) pancreatic tumors and cystic lesions. No data has suggested any advantage in obtaining both CT and MRI.
When reviewing imaging, attention should be directed specically toward evaluating:
• Relationship of any lesion to surrounding major vascular vessels, including but
not limited to the superior mesenteric artery (SMA) and vein (SMV), portal vein
(PV), and celiac trunk and its branches, including the common hepatic
artery (CHA)
• Soft tissue planes, surfaces, and/or walls of the above major vessels for any dis-
tortion or other abnormality which may suggest tumor involvement
• Any anatomical variations, most commonly a replaced right hepatic artery origi-
nating from the SMA
• Any regional lymphadenopathy
• Hepatic lesions or other distant metastases
In addition to cross-sectional imaging, endoscopic evaluation is also commonly used in the diagnostic and preoperative work-up for most pancreatic lesions.
19 Open Whipple
Endoscopic ultrasound (EUS) may be used to further characterize any lesion and evaluate any signs of vascular invasion or distortion and may be superior to CT in the detection of venous invasion specically [12, 13]. Surgeons should also keep in mind that EUS quality and interpretation are operator dependent. Endoscopic retro­grade cholangiopancreatography (ERCP) should be performed only if needed for therapeutic purposes (e.g., obstructive jaundice, etc.), due to the risk for post­procedure pancreatitis. Endoscopic ultrasound or a DOTATATE-PET can be consid­ered for patients with pancreatic neuroendocrine tumors to evaluate for additional tumors.
331
Preoperative Assessment andManagement
Patients’ baseline functional status and medical comorbidities should be thoroughly assessed and optimized as much as possible prior to surgery. Cardiac risk stratica­tion should be performed if appropriate. Baseline pancreatic endocrine and exocrine insufciency should also be assessed. It is also important to educate the patient on perioperative expectations due to the high morbidity rate associated with the Whipple operation. Perioperative assessment and postoperative complications after pancreas surgery are discussed further in later chapters.
In the cases of malignancy, venous thromboembolism (VTE) prophylaxis is rec­ommended for all patients with pancreatic cancer prior to surgery according to the American Society of Clinical Oncology (ASCO) 2019 Clinical Practice Guidelines [14]. However, while patients undergoing pancreatic resection for malignancy are certainly at higher risk for VTE, this should be balanced against the risk of periop­erative hemorrhage, and the evidence for the benet of preoperative VTE prophy­laxis specic for hepatopancreatobiliary surgery remains inconsistent. The Americas Hepato-Pancreato-Biliary Association (AHPBA) guidelines thus advocate for criti­cal thinking when weighing the potential benets and risks of preoperative VTE prophylaxis prior to major pancreatic surgery such as the Whipple [15].
Patient Positioning andSet Up
Patients should be assessed in the preoperative area for any recent changes in their medical history. In the operating room, patients should be positioned supine with arms either out or tucked, on an operating table capable of mounting appropriate self-retaining retractors. When positioning the patient’s arms, attention should be paid toward ensuring adequate room for the surgeon’s desired retractors to be con­nected to the table. Sequential compression devices or antithrombotic stockings should be placed on the lower extremities. Appropriate preoperative antibiotic pro­phylaxis such as piperacillin-tazobactam should be administered prior to incision.
332
We recommend that the entire abdomen be prepped from approximately the nip­ple line to the level of the pubic symphysis. If a vascular resection with native graft reconstruction is at all anticipated being considered, the relevant donor areas should also be prepped.
R. C. Kim et al.

Key Steps

Staging Laparoscopy
Whether a staging laparoscopy is performed to assess for small hepatic or peritoneal metastases in patients with malignancy is often dependent surgeon preference, as its yield has decreased as the quality of cross-sectional imaging has improved, but it still has a role in patients who are at increased risk for occult metastasis, such as in those with markedly elevated serum CA 19-9.
Any suspicious lesion should be biopsied and sent for pathologic review to assess for malignancy prior to proceed with the operation. Laparoscopic ultrasonography of the liver can also be considered.
Exposure andDissection
Typically, an upper midline incision provides adequate exposure to the required operative eld. Some surgeons prefer a bi-subcostal incision for patients with wide and short torsos. Once the abdomen is accessed, the falciform ligament is ligated distally and may be preserved to use as a pedicled falciform ap over the pancreati­cojejunal anastomosis. Self-retaining retractors are placed until adequate and reli­able exposure of the upper abdomen is achieved.
First, the hepatic exure is mobilized. A wide Kocher maneuver is then per­formed, mobilizing the duodenum off the retroperitoneal tissue to the ligament of Treitz, exposing the inferior vena cava to the left renal vein. At this time, the SMA can be palpated behind the pancreas to assess for tumor involvement. High-quality cross-sectional imaging that shows no evidence of SMA involvement can render this maneuver unnecessary.
Next, the lesser sac of the peritoneum is accessed. This can be achieved by either dividing the gastrocolic ligament outside of the right gastroepiploic vessels or by freeing the omentum off the transverse colon and mesocolon. The third portion of the duodenum is then dissected free from the colonic mesentery and colon, fully mobilizing the transverse colon inferiorly and off the duodenum until the inferior edge of the pancreas and the SMV are exposed. In cases of pancreatic cancer, the middle colic vein may be involved in the tumor, in which case this vessel can be sacriced. Interchangeably, entrance to the lesser sac can be done before
ab
19 Open Whipple
333
Kocherization of the duodenum. At this point, the trunk of Henle can be used as a landmark to trace the right gastroepiploic vein or the middle colic vein down to the superior mesenteric vein (Fig. 19.1a). The caudal edge of the pancreas is then exposed, and a retropancreatic tunnel is developed by blunt dissection between the pancreatic neck and portal vein (PV)-SMV conuence. Dissection directly on top of the middle of the PV-SMV conuence helps to stay in the avascular plane away from the lateral branches on both sides.
Next, attention can be turned to the hepatoduodenal ligament dissection and cre­ating the retropancreatic tunnel from above. A top-down approach is used for the cholecystectomy. Caution should be taken to avoid the right hepatic artery, which most commonly runs posterior to the hepatic duct, but in some patients may run anteriorly. Additionally, as many as 10–15% of patients possess a replaced right hepatic artery, which can be palpated in the hepatoduodenal ligament, and thus pre­operative evaluation of the patient’s vascular anatomy on cross-sectional imaging is critical (Figs.19.2 and 19.3) [18, 19].
Next, the portal triad is exposed and dissected. To achieve this, the peritoneal fat over is removed, and in this process, the right gastric artery is divided. The common hepatic artery (CHA) can be identied by the common hepatic artery node (station 8A), also known as “the node of importance.” The CHA is traced to the gastroduo­denal artery (GDA) and proper hepatic artery. The GDA is then test clamped to
Fig. 19.1 (a) The trunk of Henle may be used to identify the SMV.Here, the right gastroepiploic vein has been ligated where it drains into the SMV (black arrow and yellow vessel loop. *marks pancreas) [16]. (b) A renal pedicle clamp traversing the retropancreatic tunnel, anterior along the PV/SMV.A vessel loop is around the proper hepatic artery
334
ab
R. C. Kim et al.
ab c
Fig. 19.2 CT imaging demonstrating replaced right hepatic artery (RRHA) anatomic variations, which should be evaluated carefully during preoperative work-up and planning. (a) RRHA cours­ing posterolateral to pancreatic head. (b) RRHA traversing the pancreatic head. (c) RRHA located within the SMV groove [17]
Fig. 19.3 (a) Replaced common hepatic artery emerging between the common bile duct (left ves­sel loop) and portal vein. Top vessel loop—proper hepatic artery, bottom vessel loop—GDA. (b) Following resection, the replaced common hepatic artery coming off the SMA and coursing over the SMV/PV.Bulldog—divided hepatic duct. Sutures—pancreatic neck. Vein retractor—SMV
ascertain continued perfusion of the left and right hepatic arteries. At this point, the GDA is ligated and divided. The common hepatic duct (CHD) is then identied and dissected, and nally divided above the insertion of the cystic duct. A bulldog clamp can be placed on the proximal CHD to prevent bile spillage.
The anterior surface of the portal vein should now be exposed posterior to the GDA stump. The tunnel behind the pancreatic neck can now be completed from above along the surface of the PV. Once the tunnel is completed, a vessel loop,